TG Therapeutics Announces Approximately $85 million in Equity and Debt Financings – Nasdaq

TG Therapeutics Announces Approximately $85 million in Equity and Debt Financings  Nasdaq

NEW YORK, March 01, 2019– TG Therapeutics, Inc., a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today.

>